Elizabeth Homans - 16 Jun 2021 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Chief Executive Officer, Director
Signature
/s/ Heather Turner, as Attorney-in-fact
Issuer symbol
LYEL
Transactions as of
16 Jun 2021
Net transactions value
$0
Form type
3
Filing time
16 Jun 2021, 19:16:45 UTC
Next filing
14 Sep 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LYEL Option (right to buy) 16 Jun 2021 Common Stock 3,469,198 $0.1000 Direct F1
holding LYEL Option (right to buy) 16 Jun 2021 Common Stock 693,840 $0.1000 Direct F2
holding LYEL Option (right to buy) 16 Jun 2021 Common Stock 230,000 $3.65 Direct F3
holding LYEL Option (right to buy) 16 Jun 2021 Common Stock 3,352,300 $5.81 Direct F4
holding LYEL Option (right to buy) 16 Jun 2021 Common Stock 583,532 $6.24 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the option shares vested on September 17, 2019, with the remaining option shares to vest in equal monthly installments over the following thirty-six months. The option provides for an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
F2 1/4 of the option shares vested on November 6, 2019, with the remaining option shares to vest in equal monthly installments over the following thirty-six months. The option provides for an early-exercise provision and is exercisable as to unvested shares, subject to the Issuer's right of repurchase.
F3 The shares vest in equal monthly installments over the forty-eight months following February 1, 2020.
F4 The shares vest in equal monthly installments over the forty-eight months following August 1, 2020.
F5 The shares vest in equal monthly installments over the forty-eight months following February 12, 2021.